Among the 2633 eBC tumours from TCGA, METABRIC and PACS04, 471 (17.9%) patients had TNBC and 2162 (82.1%) had ER + /HER2− breast cancer (Supplementary Table S2). This evidence concerns the gene ERBB2 and neoplasm.